+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Insulin Pen Needles - Global Strategic Business Report - Product Thumbnail Image

Insulin Pen Needles - Global Strategic Business Report

  • Report
  • April 2026
  • 193 Pages
  • Global
From
Liraglutide Injection Market - Global Forecast to 2030 - Product Thumbnail Image

Liraglutide Injection Market - Global Forecast to 2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
From
Insulin Pens, Syringes, Pumps and Injectors Market Report 2026 - Product Thumbnail Image

Insulin Pens, Syringes, Pumps and Injectors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Blood Glucose Monitoring Devices Market 2025-2029 - Product Thumbnail Image

Blood Glucose Monitoring Devices Market 2025-2029

  • Report
  • April 2025
  • 217 Pages
  • Global
From
Drugs for Hormonal Replacement Therapy Market Report 2026 - Product Thumbnail Image

Drugs for Hormonal Replacement Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Blood Glucose Monitoring Market in APAC 2025-2029 - Product Thumbnail Image

Blood Glucose Monitoring Market in APAC 2025-2029

  • Report
  • January 2026
  • 203 Pages
  • Asia Pacific
From
From
Smart Insulin Pens & Pumps Market - Global Forecast 2026-2032 - Product Thumbnail Image

Smart Insulin Pens & Pumps Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
From
From
Loading Indicator